HELENA TURNER: Open Payments
NPI 1366927220 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 14 payments from 11 companies in 2025. Trend: 2023 $299 · 2024 $293 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Biogen, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: REXULTI, AUSTEDO XR, CAPLYTA, Auvelity, ZURZUVAE, TRINTELLIX, ARISTADA, SPRAVATO.
Industry payments across OR — which companies pay providers there.
